THIENO[2,3-C]PYRROL-4-ONE DERIVATIVES AS ERK INHIBITORS

The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.

Saved in:
Bibliographic Details
Main Authors MCMILLEN, William T, CORTEZ, Guillermo S, JOSEPH, Sajan, MCLEAN, Johnathan Alexander, RODRIGUEZ, Michael John, ZHAO, Gaiying
Format Patent
LanguageEnglish
Published 27.02.2019
Online AccessGet full text

Cover

More Information
Summary:The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.
Bibliography:Application Number: ZA20170002786